The World Health Organization R&D Blueprint aims to accelerate the availability of medical technologies during epidemics by focusing on a list of prioritized emerging diseases for which medical countermeasures are insufficient or nonexistent.

Several organizations have received a grant to create a Global Health Security Index. The Index will assess countries’ capabilities to prevent, detect, and respond to high consequence biological events.

While there are a multitude of new and improved efforts to strengthen global preparedness, there remains an overarching need to make sure residual weak spots are identified and that there is global public accountability.

As health officials, governments and global business leaders prepare for threats of global outbreaks, many are examining the ways that financial structures, supply chains, and information sharing can work together to prevent calamitous outcomes.

In the wake of the Ebola epidemic in West Africa, the World Health Organization (WHO) put forth a worldwide coalition to develop an R&D [Research and Development] Blueprint for Action to Prevent Epidemics.

This webinar discusses the development of the “Nipah R&D Roadmap,” which prioritizes the development of countermeasures (diagnostics, therapeutics and vaccines) that are most needed by Nipah-affected countries.

The Global Health Security Agenda’s Joint External Evaluation (JEE) is used as an evaluation tool to help countries assess their preparedness capacity for pandemics. Of the 27 countries with completed JEEs, only two have used the results generated to develop costed plans.